Presentation · Sep 2026 · PDF
Science
Explore conditions, clinical trials, and the latest research.
These pages contain non-exhaustive scientific information about uses of products that have not yet been approved by regulatory authorities, as their efficacy and safety for these uses have not yet been established. The information is provided for educational and scientific exchange purposes, and does not suggest products should be used in a manner not consistent with their respective label approved by the regulatory authorities, which may differ by geography. Any publication reflects the state of knowledge at the time it was published. The information is not medical advice and cannot replace the independent medical judgement of a healthcare professional.
Presentation · Sep 2026 · PDF
BBIO-Infigratinib-ESPE 2026-PROPEL Infant and Toddler
Presentation · Sep 2026 · PDF
BBIO-Infigratinib-ESPE 2026-Longer Term Results
Presentation · Sep 2026 · PDF
BBIO-Infigratinib-ESPE 2026-PROPEL3
Presentation · Aug 2026 · PDF
BBIO-Acoramidis-ESC2026-KCCQ domains by genotype-Sarswat
Presentation · Aug 2026 · PDF
BBIO-Acoramidis-ESC2026-AI (Yale) applied to 301-Baseline-Khera
Presentation · Aug 2026 · PDF
BBIO-Acoramidis-ESC 2026-DISCOVER-AI-Pedroso
Presentation · Aug 2026 · PDF
BBIO-Acoramidis-ESC2026-TRACEAI-Batinicia
Presentation · Aug 2026 · PDF
BBIO-Acoramidis-ESC2026-DLDCVH-Wright
Presentation · Aug 2026 · PDF